Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. The company was founded by Krishna Kumar Menon, George W. Evans, and Leo Ehrlich on June 20, 2007 and is headquartered in Wakefield, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Innovation Pharmaceuticals Inc market cap is $268,641.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Innovation Pharmaceuticals Inc 52 week high is $0.05 as of November 18, 2026.
Innovation Pharmaceuticals Inc stock price today is $0.0002.
Innovation Pharmaceuticals Inc stock price yesterday was $0.0005.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Innovation Pharmaceuticals Inc 50-day moving average is $0.0004.